OpenNeedle Ask your own

Question explored with the scientific record

Conversation so far

  1. 1 Connection between low b12 and autism or ADHD
  2. 2 Ok can diagnosis of b12 deficiency be measure through serum blood test’s alone
  3. 3 Therefore is it true to say that studies that do not test for mma if homocysteine are not giving a true reflection of b12 status

Answered on this page ↓

Therefore is it true to say that studies that do not test for mma if homocysteine are not giving a true reflection of b12 status

Nov 17, 2026 · 3 sources used · OpenNeedle synthesis
The short version: yes, mostly. A B12 study that never measures MMA or homocysteine is measuring the wrong thing, and it will misclassify real deficiency as normal.

The mechanism is simple. Serum B12 is a warehouse count, not a function test. MMA and homocysteine are what rise when B12 actually fails to do its job in your cells. In 434 confirmed B12 deficiency episodes, MMA was elevated in 427 and homocysteine in 416, with both elevated in 410 and normal in just 1 [1]. That is the case for calling them the functional truth.

The reverse error is just as real. More than 20% of people with serum B12 inside the reference range had raised MMA or homocysteine [3], and MMA was elevated even at B12 readings as high as 400 ng/L [3]. A study relying on serum B12 alone would call those people normal.

MarkerWhat it reflectsKey limitation
Serum total B12Circulating pool, mostly boundMisses functional deficiency [3]
MMACellular B12 functionRises with kidney impairment [2]
HomocysteineB12/folate functionRises with kidney impairment, folate [2]

So the honest answer is yes with a caveat. MMA and homocysteine are better, but neither is a gold standard. In 1,011 elderly people, kidney function tracked strongly with homocysteine and MMA but not with total B12 [2]. A study using only MMA in an elderly or kidney-impaired group can overcall deficiency. The best design uses both functional markers plus clinical context, not one lab value.

My call: studies that skip MMA and homocysteine give a distorted picture of B12 status, and you should discount their prevalence and outcome claims accordingly. Confidence: moderate.

Keep digging

Sources used 3

  1. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies The American Journal of Medicine (1994) Thin

    This study evaluates the sensitivity of serum methylmalonic acid and total homocysteine levels in diagnosing cobalamin (vitamin B12) and folate deficiencies, demonstrating their high diagnostic accuracy compared to traditional serum cobalamin measurements.

    DOI: 10.1016/0002-9343(94)90149-x
  2. Renal impairment compromises the use of total homocysteine and methylmalonic acid but not total vitamin B12 and holotranscobalamin in screening for vitamin B12 deficiency in the aged Clinical Chemical Laboratory Medicine (2007) primary study Strong

    In 1011 community-dwelling aged subjects, renal function (cystatin C) correlated with plasma total homocysteine and serum methylmalonic acid, but not with total vitamin B12 or holotranscobalamin, indicating the latter markers are preferable for B12 deficiency screening in the el…

    DOI: 10.1515/cclm.2007.028
  3. Cobalamin and Folate Evaluation: Measurement of Methylmalonic Acid and Homocysteine vs Vitamin B12 and Folate Clinical Chemistry (2000) narrative review Strong

    This review argues that methylmalonic acid and homocysteine are more sensitive metabolic indicators of functional vitamin B12 and folate deficiency than serum vitamin B12 or folate assays, which are confounded by binding proteins and analytic imprecision.

    DOI: 10.1093/clinchem/46.8.1277

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question →